Compared to No-PTX patients group, the PTX patients group had a greater percentage of hemodialysis (HD) patients, longer dialysis vintage, and a greater prevalence of more severe bone metabolism disorders such as higher ln (intact PTH) (iPTH). This evidence concerns the gene PTH and metabolic bone disorder.